Global Journal of Cancer Therapy Submit Manuscript

    Introduction

    • Volume/IssueClick here
    • Review ProcessDouble Blind
      • Publication lead time3 - 4 weeks
      • Indexing statusYes; Purview
      • Manuscript Processing ChargesClick here
      • Submission ChargesNo
      • Waiver policy for APCYes
      • Language of Full TextEnglish
      • Full-text formats availablePDF, HTML
    • Show +
    • Articles digitally archived in PORTICO
    • Permanent article identifierDOI (Digital Object Identifier) We provide DOI to all published papers to facilitate higher citation and classification of articles.
      Peertechz Publisher ID: 10.17352
    • Type of LicenseCreative Commons
      • Open AccessYes; Policy
      • Does the author retain unrestricted copyright?Yes
      • Does the author retain publishing rights?Yes
    • Show +

    Editor-in-Chief

    M.Waheed Roomi

    M.Waheed Roomi
    Dr. Rath Research Institute
    1260 Memorex Drive, Santa Clara, USA
    Email: w.roomi@drrath.com
    Tel: (408)730-4481
    Fax: (408) 588-7174

    More Info.

    Tsuyoshi Shirakawa

    Tsuyoshi Shirakawa
    Kyushu University, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan
    Email: t-w-r@intmed1.med.kyushu-u.ac.jp
    Tel: +81-92-661-5395
    Fax: +81-955-70-1511

    More Info.


    Welcome from the desk of

    Dr. Tsuyoshi Shirakawa, MD., Executive Editor

    Welcome to our website! I am very happy for your visit.

    Global Journal of Cancer Therapy reports both clinical and experimental results related to cancer, and is using online review and Editorial Manager System for quality review process. The Journal invites all type of clinical and medical case reports, case studies, basic researches, clinical images, pharmacology and nursing, as it were, total oncology. The goal of us is to keep a record of the state-of-the-art research or case report and to promote study, research and improvement within its various specialties, then to develop total oncology.

    We believe your expertise knowledge will help in the growth of the journal and as well help many budding research scientists all around the world. Your article will be a key insight into real medical cases that are essential for physicians, and may ultimately help to improve patient outcomes.

    Editorial Board

    Athanasios Papatsoris
    Urology
    Royal London Hospital
    UK
    agpapatsoris@yahoo.gr
    GJCT


    Research Interest: Endourology, Lithiasis, Laparoscopy, Prostate Cancer.

    More Info.
    Mostafa Shawky Ibrahim El-Haddad
    Assistant Professor
    Department of Clinical Oncology
    Cairo University
    Egypt
    mostafa@mostafaelhaddad.com
    GJCT

    Research Interest:  Highly Interested in Modern, Advanced Radiotherapy Techniques such as IMRT IGRT, Adaptive Radiotherapy and How to Use Them to Improve the Treatment Outcome of Cancer Patients

    More Info.
    Jinbo Gao
    Department of Gastrointestinal Surgery
    Huazhong University of Science and Technology
    China
    gaojinbo@163.com
    GJCT

    Research Interest:  Gastric Cancer; Colon Cancer; Rectal Cancer; Interferon Regulatory Factor-1 (IRF-1); Chemotherapy; Drug Resistance; Telomerase

    More Info.
    Rosaria Benedetti
    Second University of Naples Italy
    Italy
    rosaria.benedetti@gmail.com
    GJCT

    Rsearch Interest: Molecular Biology, Cell Biology, Cancer Research

    More Info.
    Fan Song
    Sun Yat-Sen University
    China
    fansong8888@163.com
    GJCT

    Research Interest: Minimal Invasion, Endoscopically Assisted Selective Neck Dissection, Functional Reconstruction, Mitochondrial Fission, Cisplatin Sensitivity, Mirna, Lncrna


    More Info.
    Maryam Azimi Mohammadabadi
    Department of Immunology
    Tehran University of Medical Science
    Iran
    m-azimim@razi.tums.ac.ir
    GJCT

    Research Interest: Potential Therapeutic Applications of Arteether, a Semi-Synthetized Derivative of Artemisinin on a Murine Model of Breast Cancer. As a Result, I Have Got Some Experience Atan Area of Tumor Immunology/Immunotherapynamed "Chemoimmunotherapy". Chemoimmunotherapy is an Approach for the Treatment of Cancers in Whichthe Focus is to enhance the Efficacy of chemotherapeutic Agents by Concomitant Application of Compounds with Immunomodulatory Properties. Besides my Thesis Work, I Managed to Do a Course in Cellular Immunology with Professor Hassan, One of the Well-Knownimmunologists in Iran, so that i could also Work on Cellular Immunology Aspects of Tumors. Moreover, Considering the Reported Associations between Molecular Players such as CTLA-4, PDL-1 and also Different Micrornas in Tumor Progression, i am Currently Planning to further Study these Associations in order to improve the Efficacy of Tumor Immunotherapy

    More Info.
    Gang Zhao
    Professor
    Department of Pancreatic Surgery
    Huazhong University of Science and Technology
    China
    gangzhao@aliyun.com
    GJCT
    More Info.
    Leonard Amaral
    Professor
    Universidade Nova de Lisboa
    Portugal
    LAmaral@ihmt.unl.pt
    GJCT

    Research Interest: Bacteriology, Immunology, Hematology, Clinical Pathology, Chemical Pathology, Endocrinology, Cancer, Human Embryology, Methods For Clinical Laboratories


    More Info.
    Grivas Nikolaos
    Associate Member of EAU
    University of Ioannina
    Greece
    ngrivas@cc.uoi.gr
    GJCT

    Research Interest: Bladder Cancer, Prostate Cancer, Renal Cancer, Urolithiasis And Uro-Gynaecology.

    More Info.
    Christopher Xin Jie Wong
    Centre for Heart Rhythm Disorders
    Royal Adelaide Hospital
    South Australia
    c.wong@adelaide.edu.au
    GJCT
    Research Interest: Dr Wong’s Research Interests Focus On The Mechanisms, Clinical Treatment And Public Health Implications Of Cardiovascular Disease.
    More Info.
    Haruo Sugiyama
    Professor
    Department of Functional Diagnostic Science
    Osaka University
    Japan
    sugiyama@sahs.med.osaka-u.ac.jp
    GJCT

    Research Interest: WT1-Specific Cytotoxic T-Lymphocytes That Have The Potential To Attack Tumor Cells


    More Info.
    Vessela Vassileva
    Research Associate
    Department of Surgery & Cancer
    UCL Cancer Institute
    UK
    vessie_vassileva@hotmail.com
    GJCT

    Research Interest: Research Interests And Career Have Focused On The Pathobiology And Treatment Of Cancer – From Identifying Key Genes And Molecular Pathways Involved In The Initiation, Development And Progression Of Cancer To Identifying Novel Treatments, Causes Of Resistance To Therapy In Solid Tumours And Strategies To Overcome Treatment Failure. She Has Wide Expertise In Oncology And Innovative Drug Development Gained From Her Academic, Publishing And Regulatory Experience.


    More Info.
    Mine Yarim
    Professor
    Yeditepe University
    Turkey
    myarim@yeditepe.edu.tr
    GJCT

    Research Interest: The Synthesis and Evaluation of New Molecules for Anticancer Activity; QSAR and Drug Design; HPLC and Chiral Separation

    More Info.
    Zhu Shu
    Yale University
    USA
    shu.zhu@yale.edu
    GJCT

    Research Interest: To Study How Our Immune Systems Recognize “Self” (The Host) Or “Non-¬‐Self” (Foreign Material) Antigens, And How The Break Of These Processes Leads To The Consequent Disease Pathology, Including Infectious Diseases And Autoimmune Diseases.


    More Info.
    Esteban Orenes-Pinero
    Associated Professor
    Deparmenr of Biochemistry & Molecular Biology
    Universidad de Murcia
    Spain
    eorenes@um.es
    GJCT

    Research Interest: Current Professional Activity: Fibrilación Auricular, Miocardiopatía Hipertrófica, Micrornas,Remodelado Cardíaco


    More Info.
    View more
    mendeley

    ANXA2 Enhances the Malignancy of Gastric Cancer Cells by Remodeling Cytoskeleton

    DOI Logo 10.17352/2581-5407.000053

    Published On: October 23, 2024 | Pages: 001 - 008

    Author(s): Yujuan Zhou, Wanlin Che, Xue Bai, Danying Zhang, Wenxuan Zhang, Hongming Fang, Guochao Nie* and Yingchun Hou*
    Abstract View Full Article View
    mendeley

    Understand the chronic pain!

    DOI Logo 10.17352/2581-5407.000052

    Published On: May 08, 2024 | Pages: 001 - 002

    Author(s): Essam Abdelrazek*
    Abstract View Full Article View
    mendeley

    Melanoma and basal cell carcinoma: Mimickers of each other

    DOI Logo 10.17352/2581-5407.000051

    Published On: September 23, 2023 | Pages: 020 - 022

    Author(s): Gustavo de Sá Menezes Carvalho*, Isabella N Dana, Juliana Casagrande Tavoloni Braga and Ashfaq A Marghoob

    ORCID Logo  0000-0002-4556-1763

    Abstract View Full Article View
    mendeley

    Flawed foundation is the root cause of failure of medicine and precludes cures for chronic diseases

    DOI Logo 10.17352/2581-5407.000050

    Published On: September 15, 2023 | Pages: 001 - 019

    Author(s): Jianqing Wu* and Ping Zha
    Abstract View Full Article View
    mendeley

    New modalities of surgery for renal tumors in children: A Mini-Review

    DOI Logo 10.17352/2581-5407.000049

    Published On: November 29, 2022 | Pages: 051 - 052

    Author(s): Jan Godzinski*
    Abstract View Full Article View    
    mendeley

    Investigation of the effectiveness of ECOLAB ’Drape ArmourTM’ Radiation Protection in limiting eye-lens doses of healthcare personnel exposed to ionizing radiation during gastroenterology - interventional radiology procedures

    DOI Logo 10.17352/2581-5407.000048

    Published On: October 20, 2022 | Pages: 046 - 050

    Author(s): Fulvio IM Fucilli*, Giuseppe Di Giovanni, Alessandro Mastrorocco, Matteo Ninni, Piero Loprete, Isa De Crudis, Massimiliano Marano, Antonio Santomauro and Fabio Fucilli

    ORCID Logo  0000-0002-1132-0363

    Abstract View Full Article View
    mendeley

    The effects of thymoquinone and cytozine arabinoside on apoptosis and cell proliferation in acute myeloide leukemia

    DOI Logo 10.17352/2581-5407.000047

    Published On: October 11, 2022 | Pages: 040 - 045

    Author(s): Aslı Altun, Nurten Kara, Şengül Tural*, Alişan Yıldıran and Leman Tomak

    ORCID Logo  0000-0002-8946-8165

    Abstract View Full Article View    
    mendeley

    A first comprehensive look at the order-disorder nature of RTK KIT native and carcinogenic targets

    DOI Logo 10.17352/2581-5407.000046

    Published On: October 07, 2022 | Pages: 036 - 039

    Author(s): Luba Tchertanov* and Julie Ledoux

    ORCID Logo  0000-0001-6600-5494

    Abstract View Full Article View    
    mendeley

    Photodynamic therapy in a pleural cavity using monte carlo simulations with 2D/3D Graphical Visualization

    DOI Logo 10.17352/2581-5407.000045

    Published On: September 29, 2022 | Pages: 034 - 035

    Author(s): Beeson K, Parilov E, Mary Potasek*, Zhu T, Sun H and Sourvanos D
    Abstract View Full Article View    
    mendeley

    Clinical trials cannot provide sufficient accuracy for studying weak factors necessary for curing chronic diseases

    DOI Logo 10.17352/2581-5407.000044

    Published On: March 23, 2022 | Pages: 021 - 033

    Author(s): Jianqing Wu* and Ping Zha
    Abstract View Full Article View    

     

    Indexing/Archiving